2026-2027 ACTUAL COMPLETE MOST TESTED REAL
EXAM QUESTIONS AND VERIFIED SOLUTIONS GET
IT 100% ACCURATE!! | ALREADY GRADED A+ |
NEWEST EXAM | JUST RELEASED!!
hypertension RELIAS
A 35-year-old G1P0 at 32 weeks presents to labor and delivery
triage with vague symptoms of malaise and decreased fetal
movement over the past 12 hours. She vomited shortly before
coming in today but, otherwise, denies abnormal symptoms.
The fetal heart rate tracing shows a baseline rate of 130 BPM
with moderate variability, and there are no decelerations or
accelerations.
Maternal blood pressure is 130/75 mm Hg, and urine dip is
negative for protein.
After calling report to the provider, labs are sent for further
information.
If the assessment is...
The patient may have HELLP syndrome.
And then you find...
Serum LDH is elevated at 650 IU/L.
Then the initial assessment becomes... - ANSWER -POSS
SUPPORTED
A 35-year-old G2P1 with a known history of well-controlled
chronic hypertension
,(BP: 130/90 mm Hg on average) has been managed on labetalol
200 mg PO BID. She is found to have elevated blood pressures
(150/100 mm Hg) at her 30week scheduled prenatal visit. She is,
otherwise, without complaints, and a urine dipstick is negative
for protein.Which of the following actions is most appropriate
at this time?
Select an answer.
Recheck maternal BP after a period of rest on her left side.
Send home and schedule outpatient BP check in 1 week.
Increase labetalol to 300 mg PO BID.
Referral to labor and delivery for further evaluation.
Send home to collect a 24-hour urine protein. - ANSWER -
further evaluation
A 36-year-old G1P0 at 32 weeks' gestation presents to labor
and delivery with a 1-day history of new-onset headaches and
worsening lower extremity edema over the preceding 2-3
weeks. Her blood pressure on presentation is 150/94 mm Hg,
and a urine dipstick reveals trace protein.
If the plan is to...
Admit patient to the hospital for preeclampsia
management.
And then you
find...
Maternal platelet count is 110,000/microliter. -
ANSWER -supported
Which of the following are considered major risk factors for the
development of preeclampsia?
,Select all that apply.
Chronic hypertension
Family history of preeclampsia
Smoking
Multiparity - ANSWER -Chronic hypertension
Family history of preeclampsia
Smoking
Ms. Sato is a 21-year-old G1P0 who begins prenatal care at 12
weeks' gestation. She is obese, with a BMI of 41, and suffers
from chronic hypertension. Which of the following proven
strategies will be recommended to Ms. Sato to lower her risk
of developing preeclampsia? Select all that apply.
Low-dose aspirin daily
Dietary salt restriction
Restriction of physical activity
Additional antioxidant medications such as vitamins C and E -
ANSWER -Lowdose aspirin daily Dietary salt restriction
Daily baby aspirin started in the late first trimester may help to
reduce the risks from preeclampsia in patients at risk based
upon which of the following? Select all that apply.
Nulliparity
Prior history of preeclampsia
Maternal systemic lupus erythematosus
Chronic hypertension
Twin gestation - ANSWER -all?
, Which of the following statements about placental
hypoperfusion/ischemia is correct?
Select all that apply.
Can be the result of chronic vascular insufficiencies such as
diabetes and lupus.
Not thought to be a central pathogenic event in early-onset
preeclampsia/HIP.
Can lead to impaired fetal growth and oligohydramnios.
Results from maternal spiral artery remodeling to high
capacity, low resistance blood vessels. - ANSWER -Can be the
result of chronic vascular insufficiencies such as diabetes and
lupus.
Can lead to impaired fetal growth and oligohydramnios.
$
Which of the following statements is false concerning
preeclampsia with severe
features?
Select an
answer.
Patients with preeclampsia with severe features should be
delivered by cesarean section.
If ≥34 weeks' gestation, a woman with preeclampsia with severe
features should be stabilized, have magnesium sulfate initiated,
and immediate delivery should occur.
If delivery is delayed for patients <34 weeks' gestation to
promote fetal lung maturity with corticosteroids, this should
be undertaken at level III or IV maternal/neonatal facilities.